96 employees
Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.
$142M sweet spot round size
Most of their 1 investments are in rounds between $142M and $142M
2009
多玛医药科技(苏州)有限公司 raised $142M on June 2, 2022
Investors: China Taiping Insurance (Australia Office), CMB International and Biocytogen